Abbott Stock: Is Wall Street Bullish or Bearish?

Lake County, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells health care products worldwide. The company has a market cap of $182.9 billion and operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices segments and offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, and more.

Shares of Abbott have underperformed the broader market over the past year, declining 19.1% compared to the S&P 500 Index’s ($SPX) 22.6% surge. Moreover, in 2026, the stock has fallen by nearly 15.6%, also lagging behind the SPX’s 8.5% gain.